Brief

The French National Agency for Medicines and Health Products Safety (ANSM) conducted an inspection at Sofibel's Levallois-Perret facility from June 12 to 14, 2024. The inspection revealed significant non-conformities and shortcomings, which were notified to the establishment in a letter on August 20, 2024. The ANSM found insufficient controls over critical suppliers and subcontractors, inadequate technical documentation for the Sterimar product, and insufficient biocharge management. As a result, Sofibel was ordered to establish satisfactory measures within specified timeframes.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies